Cecilia Brain, MD, PhD, is clinically active as a Senior Consultant in Psychiatry at the Psychosis Clinic, Sahlgrenska University Hospital, Gothenburg, Sweden, where I work according to an evidence-based Assertive Community Treatment (ACT) model treating schizophrenia and other psychotic disorders. Currently I promote the government-initiated implementation of evidence-based psychiatric care, Case Management and Flexible-ACT (FACT) in Sweden.
I have a Ph.D in medicine at the University of Gothenburg, Sweden, within the field of adherence in schizophrenia, and have recent publications on adherence in peer-reviewed journals. Other current research projects are focused on cognition and stigma in schizophrenia. Additionally I am continuously involved in ongoing pharmaceutical studies (antipsychotics) both as a National and Principal Investigator.
I am a member of the steering committee of the World Psychiatric Association (WPA), Scientific Section of Mental Health as well as several national and international expert groups and advisory boards. I am also on the board for the Swedish Psychiatry Fund, which aims at improving attitudes towards psychiatry through fund raising, collaboration with a broad range of main opinion leaders and by organizing public events and supporting research. As a frequent lecturer within my field of expertise I have established several international research networks, such as with the WPA, the University of Manchester, Newcastle University, the Association for Improvement of the Mental Health Programmes, Geneva and the Institute of Psychiatry, London, as well as with the Hotchkiss Brain Institute of Calgary, as part of collaborative studies.
I have authored several academic book chapters and am the chief editor and co-author of a recent Swedish book about evidence-based psychiatry, Integrerad Psykiatri. Case management i teori och praktik. I am a frequent peer-reviewer for scientific journals and an Editorial Board Member of the International Journal of Neurology Research and the Swedish Editor of the international journals Framingham on Schizophrenia and Bipolar Disorders, and Best Practice Psychiatry and Neurology.